Company | Everest Group, Ltd. |
Ticker | NYSE: EG |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | July 29–30, 2026 |
Prepared Date | July 28, 2026 |
Sector ETF Benchmark | IAK (iShares U.S. Insurance ETF) |
Key Takeaway: Setup is constructive but not clean — the bar is beatable on underwriting (consensus combined ratio of ~92.0% vs. EG’s Q1 2026 actual of 91.2%), but the single biggest swing factor is whether the Baltimore Bridge reserve development materializes in Q2 (management flagged “a few tens of millions” of incremental prior-year development possible in Q2 or Q3) and how much property cat pricing softness flows through net premium written.
Heading into Q2 2026, Everest’s setup is one of improving underlying quality against a backdrop of deliberate top-line contraction and a still-uncertain cat reserve item. Consensus operating EPS of $14.74 represents a meaningful step-down from Q1’s $16.08 actual, largely reflecting the absence of the outsized alternative investment income that boosted Q1, and the bar on net premium written ($3.37B consensus) is already discounting the ongoing casualty runoff and retail exit — making a volume beat less likely but also less necessary. Management’s tone on the Q1 call was confident on underwriting trajectory (attritional combined ratio improving 3.8 pts in GW&S to 58.9%) while explicitly cautious on property cat pricing (rates down 13% at April 1, mid-teens declines expected at 6/1 Florida), and the launch of the Annapurna Re casualty sidecar ($600M third-party capital) signals conviction in the casualty book’s quality. Estimate revisions have been modestly positive since the Q1 print — FY2026 operating EPS consensus moved from $53.19 to $51.50 (a slight downward drift), while the stock has rallied ~15.9% since last earnings vs. IAK +15.7% and SPY +4.1%, suggesting the market has already priced in meaningful execution progress. The wildcard is the Baltimore Bridge: management guided to “a few tens of millions” of incremental prior-year development in Q2 or Q3, and peer RenaissanceRe (RNR) confirmed in its Q2 2026 call that the industry loss estimate grew materially, with RNR itself booking 4.1 points of adverse development from the bridge — this is the most likely source of a negative surprise for EG in Q2.
Key Takeaway: Consensus is a moderate bar on underwriting (combined ratio ~92.0% vs. Q1 actual 91.2%), but operating EPS ($14.74) is the bigger swing factor given sensitivity to cat activity and alternative investment income. Net premium written is the secondary watch item given ongoing portfolio reshaping.
Table 1 — Q2 2026 Current Quarter Snapshot
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance | Consensus vs. Guidance |
Operating EPS (Diluted) | $16.08 | $17.56 | $14.74 | -16.1% | No specific Q2 guidance; FY2026 implied ~$51.50 | N/A (no quarterly guide) |
Combined Ratio (%) | 91.2% | 90.4% | 92.0% | +160 bps | Legacy >110% for FY2026; GW&S targeting low-90s | Broadly in line with guidance range |
Net Premium Written | $3.186B | $4.119B | $3.367B | -18.3% | No specific quarterly guide; FY2026 ~$13.14B | N/A (no quarterly guide) |
Net Investment Income | $567M | $532M | $496M | -6.8% | Flat to marginal AUM growth; ~$60M annual drag from ADC | Consensus below prior year; reflects ADC drag |
Attritional Combined Ratio (%) | 88.5% | 88.4% | 88.8% | +40 bps | GW&S targeting lower-90s; Reinsurance improving | Broadly in line |
Total Cat Loss Ratio (%) | 3.6% | 0.5% | 3.2% | +270 bps | Cat load ~7% annually; Q2 typically lower cat quarter | Consensus below annual load; assumes benign Q2 |
Total Revenues | $4.068B | $4.492B | $4.033B | -10.2% | Declining due to retail exit; FY2026 ~$15.95B | Consensus reflects deliberate top-line contraction |
Source: Visible Alpha consensus and actuals data. All consensus figures as of July 28, 2026.
Table 2 — Beat/Miss History: Operating EPS & Combined Ratio (Last 8 Quarters)
Quarter | Op. EPS Reported | Op. EPS Consensus | EPS Surprise % | EPS Result | Comb. Ratio Reported | Comb. Ratio Consensus | CR Surprise |
Q1 2026 | $16.08 | $13.95 | +15.3% | BEAT | 91.2% | 92.9% | Better (170 bps) |
Q4 2025 | $13.24 | $13.61 | -2.7% | MISS | 98.4% | 96.5% | Worse (190 bps) |
Q3 2025 | $7.55 | $14.58 | -48.2% | MISS | 103.4% | 92.9% | Worse (1050 bps) |
Q2 2025 | $17.56 | $15.00 | +17.1% | BEAT | 90.4% | 91.9% | Better (150 bps) |
Q1 2025 | $6.45 | $7.63 | -15.5% | MISS | 102.7% | 101.4% | Worse (130 bps) |
Q4 2024 | -$18.39 | -$16.06 | N/M (large loss qtr) | MISS | 135.5% | 134.0% | Worse (150 bps) |
Q3 2024 | $14.62 | $12.08 | +21.0% | BEAT | 93.1% | 96.3% | Better (320 bps) |
Q2 2024 | $16.85 | $16.66 | +1.1% | BEAT | 90.3% | 89.7% | Worse (60 bps) |
Source: Visible Alpha consensus and actuals data.
Pattern: EG has beaten operating EPS in 4 of the last 8 quarters, with misses concentrated in quarters with elevated catastrophe or reserve charges (Q4 2024, Q3 2025, Q1 2025); the two most recent clean quarters (Q2 2025, Q1 2026) were both significant beats, suggesting the underlying business is tracking above consensus when cat/reserve noise is absent.
Key Takeaway: No formal guidance revisions since the Q1 2026 earnings call (April 29, 2026), but the launch of Annapurna Re (June 17) and the Colombia sale announcement (May 19) represent meaningful strategic updates. Management tone remains confident on underwriting trajectory while explicitly cautious on property cat pricing and Baltimore Bridge reserve development.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 29) | Revised Guidance | Current Consensus | Note |
Share Repurchase Floor (Quarterly) | Raised to $300M/quarter (from $200M), effective Q2 2026, absent major external dislocation | — | Elevated payout ratio expected for FY2026 | ↑ Raised at Q1 earnings call; signals strong conviction stock is undervalued |
Legacy Segment Combined Ratio (FY2026) | >110% for FY2026, driven by retail-to-AIG transition expenses | — | ~135% in Q4 2024; improving but still elevated | Unchanged; ~$150M restructuring charges expected throughout 2026 |
Underwriting Expense Ratio (Group) | 6%–7% range for FY2026; not expected below 6% for any meaningful period | — | GW&S operating expense ratio at 12.6% in Q1; expected to improve as business scales | Unchanged; elevated real estate costs expected in Q4 2026 |
Operating Tax Rate (FY2026) | 17%–18% working assumption for full year (Q1 actual was 11.7%, below guidance) | — | N/A — not separately tracked in VA | Unchanged; Q1 benefited from discrete tax items |
Property Cat Pricing (6/1 Florida Renewals) | Mid-teens rate declines expected at 6/1 Florida; terms and conditions expected to hold; returns remain above thresholds | — | Peer RNR confirmed high-teens declines at mid-year; broadly consistent with EG guidance | Unchanged; RNR Q2 2026 call confirmed pricing pressure consistent with EG’s April guidance |
Baltimore Bridge Reserve Development | Initial reserve $70M; “a few tens of millions” of incremental development possible in Q2 or Q3 via prior-year development line | — | N/A — not in VA consensus | ⚠ Key risk: RNR booked 4.1 pts adverse development from bridge in Q2 2026; EG may follow |
Capital Release from Retail Exit (AIG Transaction) | Meaningful capital release expected to become visible in H2 2026; Canada sale ~6 months from close | — | Colombia operations sale to AIG announced May 19, 2026 (expected close early 2027) | ↑ Colombia sale (May 19) adds another retail exit step; accretive to capital return discussion |
Net Investment Income / AUM Growth | Flat to marginal AUM growth; ~$60M annual NII drag from ADC transaction | — | $496M Q2 2026 consensus (vs. $567M Q1 2026 actual) | Unchanged; Q1 NII was boosted by outsized alternative investment returns (not expected to repeat) |
Key Takeaway: FY2026 operating EPS estimates have drifted modestly lower since the Q1 print (from $53.19 to $51.50, -3.2%), while Q2 2026 estimates are essentially flat since the post-Q1 baseline. The gap between current consensus and management’s implied FY guidance is not alarming, but the downward drift in FY EPS reflects the market pricing in the ADC-related NII drag and continued top-line contraction from the retail exit.
KPI & Period | Estimate ~5 Days Post Q1 Earnings (as of May 6, 2026) | Current Consensus (Jul 28, 2026) | Estimate Δ (%) | Initial Guidance (Q1 2026 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Op. EPS — Q2 2026 | $14.63 | $14.74 | +0.8% | No quarterly guide | No quarterly guide | N/A | N/A |
Op. EPS — FY2026 | $53.19 | $51.50 | -3.2% | No formal FY EPS guide; implied ~$51–$57 range from analyst models | Unchanged | N/A | N/A |
Combined Ratio — Q2 2026 | 92.4% | 92.0% | -40 bps | No quarterly guide; GW&S targeting low-90s | Unchanged | N/A | Broadly in line |
Combined Ratio — FY2026 | 94.6% | 94.8% | +20 bps | Legacy >110%; GW&S low-90s; Reinsurance improving | Unchanged | N/A | Broadly in line |
Net Premium Written — Q2 2026 | $3.552B | $3.367B | -5.2% | No quarterly guide; FY2026 ~$13.14B | Unchanged | N/A | N/A |
Net Premium Written — FY2026 | $13.620B | $13.142B | -3.5% | No formal guide; deliberate casualty runoff + retail exit | Unchanged | N/A | N/A |
Net Investment Income — Q2 2026 | $505M | $496M | -1.8% | Flat to marginal AUM growth; ~$60M annual ADC drag | Unchanged | N/A | Broadly in line |
Source: Visible Alpha consensus and actuals data. Post-Q1 baseline as of May 6, 2026 (5 trading days after April 29, 2026 earnings release).
The modest downward drift in FY2026 EPS (-3.2%) and NPW (-3.5%) since the Q1 print reflects the market incorporating the ADC-related NII headwind and continued top-line contraction from the retail exit, rather than any deterioration in underlying underwriting quality. Combined ratio estimates have been essentially stable, consistent with management’s guidance for improving attritional performance.
Key Takeaway: EG has rallied ~15.9% since the Q1 2026 earnings date (April 29, 2026), essentially in line with the insurance sector (IAK +15.7%) but well ahead of the S&P 500 (+4.1%), suggesting the re-rating has been sector-driven rather than EG-specific alpha. The stock’s recovery from a mid-May/early-June trough (driven by property cat pricing concerns) was catalyzed by the Annapurna Re sidecar launch and multiple analyst price target upgrades in early July.
EG vs. IAK (iShares U.S. Insurance ETF) vs. S&P 500 — Indexed to 100 at April 29, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance.
Key events since Q1 2026 earnings (April 29, 2026):
Analyst Consensus (as of July 28, 2026): 16 analysts covering EG; consensus rating Hold (12 Hold, 4 Buy, 0 Sell). Average price target ~$375–$388 (range: $287–$484). Stock at ~$398.70 (July 29 pre-market) is trading above the consensus price target, suggesting the market is pricing in a beat or further re-rating.
Key Takeaway: The most important development since Q1 earnings is the launch of Annapurna Re (June 17), which signals third-party investor confidence in Everest’s casualty underwriting quality and expands the capital-light earnings model — a direct positive read-through for Q2 and beyond. The Baltimore Bridge reserve development remains the key downside risk to watch in the Q2 print.
Key Takeaway: Peer commentary from the last 60 days is broadly constructive for EG’s Q2 setup: property cat pricing softened as expected (high-teens at mid-year, consistent with EG’s April guidance), underwriting discipline is holding on terms and conditions, and casualty reserve trends are mixed but manageable. The Baltimore Bridge is the most consistent negative read-through across peers. RNR’s Q2 2026 call (July 23) is the most directly relevant, as it covers the same reporting quarter as EG.
Note on peer selection: Only commentary about Q2 2026 conditions or forward-looking statements made after Q1 2026 earnings is included. Q1 2025 results commentary has been excluded. RNR reported Q2 2026 on July 23, 2026 (same quarter as EG). HG and SPNT reported Q1 2026 in May 2026 but provided forward-looking commentary about Q2 2026 and mid-year renewals.
Relevance: RNR is EG’s closest pure-play reinsurance peer and reported Q2 2026 on July 23 — the most timely and directly comparable read-through available. RNR’s commentary covers the same mid-year renewal period and cat environment that will drive EG’s Q2 results.
Relevance: HG provided forward-looking commentary on mid-year renewals and Q2 2026 conditions, including specific guidance on Florida 6/1 renewals and the Middle East conflict impact. HG’s Bermuda-focused reinsurance book overlaps meaningfully with EG’s Reinsurance segment.
Relevance: SPNT provided forward-looking commentary on Q2 2026 and full-year 2026 conditions, including specific guidance on property cat pricing, casualty reserve trends, and combined ratio trajectory. SPNT’s diversified reinsurance/insurance model overlaps with EG’s GW&S segment.
Peer Commentary Summary Table
Theme | RNR (Q2 2026, Jul 23) | HG (Q1 2026, May 1) | SPNT (Q1 2026, May 8) | EG Read-Through |
Property Cat Pricing | High-teens declines; rates broadly adequate; grew limit | Similar pressure to YTD; margins above thresholds; T&C holding | ~15% declines; Q1 was most extreme shrinkage; improving H2 | Neutral-to-positive: pricing soft but adequate; EG’s discipline should protect margins |
Baltimore Bridge | 4.1 pts adverse development in Q2; $12M net impact | $14M adverse development in Q1 (2.4 pts) | No significant impact noted | Negative: EG likely books $20–50M incremental development in Q2 |
Casualty Reserves | Cautious; social inflation ongoing; favorable ex-bridge | Favorable history; no material casualty issues | 20 consecutive quarters favorable; prudent approach | Neutral: EG’s ADC provides finality; underlying casualty improving |
Combined Ratio Trend | 72% adjusted; strong property cat accident year | 89.8% group; dramatic improvement from Q1 2025 | 88.9% core; lowest in 6 quarters; 14th consecutive underwriting profit | Positive: sector-wide attritional improvement supports EG’s ~92% Q2 consensus |
Middle East / Iran | Not specifically called out in Q2 | Manageable; losses to continue; inflationary risk | Minimal claims noted | Watch: EG has $58M Q1 provision; incremental Q2 exposure possible |
Capital / Sidecars | Chose not to deploy Epsilon at mid-year; ceded 35% of C&S gross premium | $300M casualty sidecar launched in Q1 | $135M buyback authorization remaining; may use special dividend | Positive: EG’s $600M Annapurna Re is sector-leading; $300M/qtr buyback floor |
Key Takeaway: The only open-market sale since Q1 earnings was a small discretionary sale by Jason Keen (EVP & CEO of GW&S Division) of 775 shares on May 7 — modest in size and not a meaningful signal. Director share awards (transaction code ‘A’) are routine compensation grants, not open-market purchases. No clustered open-market buys or unusual sale activity; insider activity is quiet heading into Q2 earnings.
Name | Title | Transaction Type | Shares / Value | Transaction Date | Note |
Jason Keen | EVP & CEO, GW&S Division | Open Market Sale | 775 shares / ~$272,676 (avg. $351.84/sh) | May 7, 2026 | Discretionary sale; small relative to 8,170 shares remaining post-sale; not a significant signal |
Elias F. Habayeb | EVP & CFO | Award (Compensation Grant) | 21,098 shares awarded | May 12, 2026 | Routine equity compensation grant to new CFO; not an open-market purchase |
Meryl D. Hartzband | Director | Award (Compensation Grant) | 86 shares awarded | July 1, 2026 | Routine director equity compensation; not an open-market purchase |
John M. Howard | Director | Award (Compensation Grant) | 86 shares awarded | July 1, 2026 | Routine director equity compensation; not an open-market purchase |
Allan Levine | Director | Award (Compensation Grant) | 86 shares awarded | July 1, 2026 | Routine director equity compensation; not an open-market purchase |
Source: SEC Form 4 filings via insider transaction data.
No open-market buys have been filed by insiders since Q1 2026 earnings. The only open-market sale (Jason Keen, 775 shares) is small and not a meaningful bearish signal. The absence of insider buying is notable given management’s stated conviction that the stock is undervalued — though the company’s own $300M/quarter buyback program is the primary vehicle for expressing that conviction.